IRIS
QUARTO, RODOLFO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.425
Totale 14.425
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.425
Totale 14.425
Salva come PNG Salva come JPEG
Città #
Genova 12.073
Rapallo 1.313
Genoa 996
Bordighera 43
Totale 14.425
Salva come PNG Salva come JPEG
Nome #
Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics 238
Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. 150
Atomic force microscopy for biomechanical and structural analysis of human dermis: A complementary tool for medical diagnosis and therapy monitoring 149
TGF β-1 administration during ex-vivo expansion of human articular chondrocytes in a serum-free medium redirects the cell phenotype toward hypertrophy. 143
Demethyl fruticulin A (SCO-1) causes apoptosis by inducing reactive oxygen species in mitochondria 142
A simple non invasive computerized method for the assessment of bone repair within osteoconductive porous bioceramic grafts 141
Flow cytometric evaluation of cell cycle characteristics during in vitro differentiation of chick embryo chondrocytes. 140
In vivo lamellar bone formation in fibre coated MgCHA-PCL-composite scaffolds. 138
Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice 136
Design and characterization of a tissue-engineered bilayer scaffold for osteochondral tissue repair 135
A composite material model for improved bone formation. 130
Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling. 128
Skin Rejuvenation and Volume Enhancement with the Micro Superficial Enhanced Fluid Fat Injection (M-SEFFI) for Skin Aging of the Periocular and Perioral Regions 128
Rheological properties, biocompatibility and in vivo performance of new hydrogel-based bone fillers 128
DLX5 overexpression impairs osteogenic differentiation of human bone marrow stromal cells. 127
Bone marrow stromal cells and their use in regenerating bone. 127
Interaction Between Breast Cancer Cells and Adipose Tissue Cells Derived from Fat Grafting 127
Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism. 126
Engineering of osteoinductive grafts by isolation and expansion of ovine bone marrow stromal cells directly on 3D ceramic scaffolds 125
Osteoconduction in large macroporous hydroxyapatite ceramic implants: evidence for a complementary integration and disintegration mechanism 123
Osteogenic potential of rat spleen stromal cells 120
In vitro development of hypertrophic chondrocytes starting from selected clones of dedifferentiated cells. 119
Osteoinduction of Human Mesenchymal Stem Cells by Bioactive Composite Scaffolds without Supplemental Osteogenic Growth Factors. 119
"Green-reduced" graphene oxide induces in vitro an enhanced biomimetic mineralization of polycaprolactone electrospun meshes 119
Bone marrow stromal damage after chemo/radiotherapy: occurrence, consequences and possibilities of treatment 118
Microenvironment and stem properties of bone marrow-derived mesenchymal cells 115
Tissue engineering and cell therapy of cartilage and bone 115
Cell condensation in chondrogenic differentiation. 115
Clinical Applications of Bone Tissue Engineering 115
Superficial Enhanced Fluid Fat Injection (SEFFI) to correct volume defects and skin aging of the face and periocular region 114
Repair of large bone defects with the use of autologous bone marrow stromal cells 114
The administration of demethylfruticulin A from Salvia corrugata to mammalian cells lines induces‘‘anoikis’’, a special form of apoptosis 114
Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells 113
Design of graded biomimetic osteochondral composite scaffolds. 113
Human bone marrow stromal cells hamper specific interactions of CD4 and CD8 T lymphocytes with antigen-presenting cells 112
Collagen distribution in endochondral cartilage obtained 'in vitro' by dedifferentiated cells 112
Circulating healing (CH) cells expressing BST2 are functionally activated by the injury-regulated systemic factor HGFA 112
Generation of a Functional Human Neural Network by NDM29 Overexpression in Neuroblastoma Cancer Cells 112
From stem cells to tissue-specific differentiation. 111
Chondrocyte differentiation in vitro from clones of prechondrogenic cells 111
A computer-based technique for cell aggregation analysis: cell-condensation in "in vitro" chondrogenesis 111
Novel nanostructured scaffold for osteochondral regeneration: pilot study in horses. 110
SVILUPPO DI UN CEMENTO OSSEO A BASE DI FOSFATO DI CALCIO PER LA RIGENERAZIONE OSSEA. 110
A comparative evaluation between new ternary zirconium alloys as alternative metals for orthopedic and dental prosthetic devices 110
A nude mouse model for human bone formation in unloaded conditions. 109
Cell therapy for bone disease: a review of current status 108
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 108
New collagen- or hydrogel-based bone fillers: rheological properties, biocompatibility and in vitro and in vivo exploitation tests 107
Differences in chemical composition and internal structure influence systemic host response to implants of biomaterials. 107
Fluorescence microscopy imaging of bone for automated histomorphometry 106
Bone progenitor cell deficits and the age-associated decline in bone repair capacity. 106
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease 105
Isolation and Flow Cytometry Characterization of Extracellular-Vesicle Subpopulations Derived from Human Mesenchymal Stromal Cells 105
Hydroxyapatite-coated polycaprolacton wide mesh as a model of open structure for bone regeneration. 104
Gene expression profile of human bone marrow stromal cells determined by restriction fragment differential display analysis 104
A three-dimensional traction/torsion bioreactor system for tissue engineering 103
Cell therapy: filling the gap between basic science and clinical trials October 15-17, 2001, Rome, Italy. 103
In vitro morphogenesis of chick embryo hypertrophic cartilage. 103
Preparation and properties of macroporous brushite bone cements 103
Thyroid hormone, insulin, and glucocorticoids are sufficient to support chondrocyte differentiation to hypertrophy: a serum-free analysis. 103
Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration 102
The receptor for immunoglobulin E: examination for kinase activity and as a substrate for kinases. 102
A novel scaffold geometry for chondral applications: Theoretical model and in vivo validation 102
Effects of fluid flow and calcium phosphate coating on human bone marrow stromal cells cultured in a defined 2D model system. 102
Response of osteoblast-like MG63 on neoglycosylated collagen matrices 101
Liver xenoassistance: biosafety. 101
Exposure to reversine affects the chondrocyte morphology and phenotype in vitro 101
Noncovalently and covalently bound lipid on the receptor for immunoglobulin E. 101
Orderly osteochondral regeneration in a sheep model using a novel nano-composite multilayered biomaterial. 101
Exposure to reversine affects the chondrocyte morphology and phenotype in vitro 100
Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. 98
Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. 97
Chronic lymphocytic leukemic (CLL) B cells express the HGF receptor (C-MET) and are supported in their survival by HGF-producing mesenchymal stromal cell 97
Reverse-flow perfusion of three-dimensional scaffolds 96
Osteogenic differentiation of human mesenchymal stromal cells on surface-modified titanium alloys for orthopedic and dental implants 96
Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells 96
Mesenchymal stem cell culture in convection-enhanced hollow fibre membrane bioreactors for bone tissue engineering 96
Cell therapy and bone repair 96
Bone invading NSCLC cells produce IL-7: mice model and human histologic data 96
Order versus Disorder: in vivo bone formation within osteoconductive scaffolds 96
Defining an optimal stromal derived factor-1 presentation for effective recruitment of mesenchymal stem cells in 3D 96
Bone structural similarity score: a multiparametric tool to match properties of biomimetic bone substitutes with their target tissues 95
Topographical Features of Graphene-Oxide-Functionalized Substrates Modulate Cancer and Healthy Cell Adhesion Based on the Cell Tissue of Origin 95
Synthesis and secretion of Ch 21 protein in embryonic chick skeletal tissue 95
Calcification of in vitro developed hypertrophic cartilage 94
Bioreattore, in particolare per la generazione di tessuti ingegnerizzati 93
In vivo and in vitro effects of insulin-like growth factor-I (IGF-I) on femoral mRNA expression in old rats. 93
C6: A monoclonal antibody specific for a fibronectin epitope situated at the interface between the oncofoetal extra-domain B and the repeat III8 92
ATTIVITÀ BIOLOGICA DI COMPOSTI ISOLATI DA SALVIA CORRUGATA 91
The receptor with high affinity for immunoglobulin E. 91
Reconstruction of extensive long-bone defects in sheep using porous hydroxyapatite sponges. 90
Chemical and morphological gradient scaffolds to mimic hierarchically complex tissues: From theoretical modeling to their fabrication 87
Ex vivo enrichment of mesenchymal cell progenitors by FGF-2 87
Enhanced mechanical performances and bioactivity of cell laden-graphene oxide/alginate hydrogels open new scenario for articular tissue engineering applications 87
Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1 86
Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model 83
Bone tissue engineering: Past-present-future 83
Mesenchymal Stem Cells induce functionally active T regulatory lymphocytes in a paracrine fashion and ameliorate Experimental Autoimmune Uveitis. 82
Proliferation kinetics and differentiation potential of "ex vivo" expanded human bone marrow stromal cells: implications for their use in cell therapy 81
Articular chondrocytes culturing conditions: optimizations and drawbacks for cartilage resurfacing attempts 81
Totale 10.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.444
article - articoli 32.124
book - libri 0
conference - conferenze 3.007
curatela - curatele 0
other - altro 0
patent - brevetti 693
selected - selezionate 0
volume - volumi 2.620
Totale 76.888
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019800 0 0 0 0 0 0 0 0 0 0 436 364
2019/20204.423 170 109 178 260 413 485 799 287 396 712 454 160
2020/20211.041 70 107 67 94 65 80 38 120 112 125 80 83
2021/20222.022 55 190 177 207 90 90 161 443 81 187 116 225
2022/20231.613 183 111 19 143 268 247 8 137 296 10 168 23
2023/2024753 43 130 16 106 48 194 48 97 48 23 0 0
Totale 14.636